IFNG and viral infectious disease: Therapies targeting the JAK family of enzymes may interfere with a normal antiviral response, including inhibition of IFN-γ activity, and may potentially increase the risk of infection/ reactivation of several viral infectious diseases, particularly HZ in rheumatoid arthritis patients14,38.